ArticleThe Journal of infection2023
Post-acute hospitalization and mortality of nirmatrelvir plus ritonavir for COVID-19 survivors.
Wan-Hsuan Hsu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this paperpooled itcites it